Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer.
Attard G, Clark J, Ambroisine L, Mills IG, Fisher G, Flohr P, Reid A, Edwards S, Kovacs G, Berney D, Foster C, Massie CE, Fletcher A, De Bono JS, Scardino P, Cuzick J, Cooper CS; Transatlantic Prostate Group. Attard G, et al. Among authors: foster c. Br J Cancer. 2008 Jul 22;99(2):314-20. doi: 10.1038/sj.bjc.6604472. Epub 2008 Jul 1. Br J Cancer. 2008. PMID: 18594527 Free PMC article.
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate.
Clark J, Merson S, Jhavar S, Flohr P, Edwards S, Foster CS, Eeles R, Martin FL, Phillips DH, Crundwell M, Christmas T, Thompson A, Fisher C, Kovacs G, Cooper CS. Clark J, et al. Among authors: foster cs. Oncogene. 2007 Apr 19;26(18):2667-73. doi: 10.1038/sj.onc.1210070. Epub 2006 Oct 16. Oncogene. 2007. PMID: 17043636
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.
Attard G, Clark J, Ambroisine L, Fisher G, Kovacs G, Flohr P, Berney D, Foster CS, Fletcher A, Gerald WL, Moller H, Reuter V, De Bono JS, Scardino P, Cuzick J, Cooper CS; Transatlantic Prostate Group. Attard G, et al. Among authors: foster cs. Oncogene. 2008 Jan 10;27(3):253-63. doi: 10.1038/sj.onc.1210640. Epub 2007 Jul 16. Oncogene. 2008. PMID: 17637754 Free PMC article.
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype.
Mitra A, Fisher C, Foster CS, Jameson C, Barbachanno Y, Bartlett J, Bancroft E, Doherty R, Kote-Jarai Z, Peock S, Easton D; IMPACT and EMBRACE Collaborators; Eeles R. Mitra A, et al. Among authors: foster cs. Br J Cancer. 2008 Jan 29;98(2):502-7. doi: 10.1038/sj.bjc.6604132. Epub 2008 Jan 8. Br J Cancer. 2008. PMID: 18182994 Free PMC article.
Concepts of epigenetics in prostate cancer development.
Cooper CS, Foster CS. Cooper CS, et al. Among authors: foster cs. Br J Cancer. 2009 Jan 27;100(2):240-5. doi: 10.1038/sj.bjc.6604771. Epub 2008 Nov 11. Br J Cancer. 2009. PMID: 19002169 Free PMC article. Review.
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.
Cuzick J, Berney DM, Fisher G, Mesher D, Møller H, Reid JE, Perry M, Park J, Younus A, Gutin A, Foster CS, Scardino P, Lanchbury JS, Stone S; Transatlantic Prostate Group. Cuzick J, et al. Among authors: foster cs. Br J Cancer. 2012 Mar 13;106(6):1095-9. doi: 10.1038/bjc.2012.39. Epub 2012 Feb 23. Br J Cancer. 2012. PMID: 22361632 Free PMC article.
3,301 results